Dr. Barbara Timmermann leads the COBRE initiative for the Center for Cancer
Experimental Therapeutics. Dr. Timmermann is a University Distinguished
Professor and Chair of the Department of Medicinal Chemistry, University
of Kansas, Lawrence. btimmer@ku.edu http://www.medchem.ku.edu/faculty_timmermann.shtml